These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12794859)

  • 21. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
    Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
    Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity.
    Ayan D; Roy J; Maltais R; Poirier D
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):324-30. PubMed ID: 21827856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological evaluation of novel estrogen-platinum(II) hybrid molecules on uterine and ovarian cancers-molecular modeling studies.
    Gagnon V; St-Germain ME; Descôteaux C; Provencher-Mandeville J; Parent S; Mandal SK; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5919-24. PubMed ID: 15501069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A series of unconjugated ferrocenyl phenols: prospects as anticancer agents.
    Hillard E; Vessières A; Le Bideau F; Plazuk D; Spera D; Huché M; Jaouen G
    ChemMedChem; 2006 May; 1(5):551-9. PubMed ID: 16892391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioiodinated ligands for the estrogen receptor: effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6-dehydroestradiols.
    Neto C; Oliveira MC; Gano L; Marques F; Santos I; Morais GR; Yasuda T; Thiemann T; Botelho F; Oliveira CF
    Appl Radiat Isot; 2009 Feb; 67(2):301-7. PubMed ID: 19049850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
    Perron V; Rabouin D; Asselin E; Parent S; C-Gaudreault R; Bérubé G
    Bioorg Chem; 2005 Feb; 33(1):1-15. PubMed ID: 15668178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of estradiol-chlorambucil hybrids as anticancer agents.
    Gupta A; Saha P; Descôteaux C; Leblanc V; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1614-8. PubMed ID: 20137939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 7α-alkoxy-17α-(4'-halophenylethynyl)estradiols as potential SPECT/PET imaging agents for estrogen receptor expressing tumours: synthesis and binding affinity evaluation.
    Neto C; Oliveira MC; Gano L; Marques F; Yasuda T; Thiemann T; Kniess T; Santos I
    Steroids; 2012 Sep; 77(11):1123-32. PubMed ID: 22633985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
    Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
    Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
    Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntheses and affinities of novel organometallic-labeled estradiol derivatives: a structure-affinity relationship.
    el Amouri H; Vessières A; Vichard D; Top S; Gruselle M; Jaouen G
    J Med Chem; 1992 Aug; 35(17):3130-5. PubMed ID: 1507201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
    Zheng ZY; Lin VC
    Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
    Fournier D; Poirier D
    Eur J Med Chem; 2011 Sep; 46(9):4227-37. PubMed ID: 21782294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol.
    Toran-Allerand CD
    Ann N Y Acad Sci; 2005 Jun; 1052():136-44. PubMed ID: 16024756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deconstructing estradiol: removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists.
    Asim M; El-Salfiti M; Qian Y; Choueiri C; Salari S; Cheng J; Shadnia H; Bal M; Christine Pratt MA; Carlson KE; Katzenellenbogen JA; Wright JS; Durst T
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1250-3. PubMed ID: 19167882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MTD-PLS: a PLS variant of the minimal topologic difference method. III. Mapping interactions between estradiol derivatives and the alpha estrogenic receptor.
    Kurunczi L; Seclaman E; Oprea TI; Crisan L; Simon Z
    J Chem Inf Model; 2005; 45(5):1275-81. PubMed ID: 16180904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
    Walter G; Liebl R; von Angerer E
    Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents.
    Shankar R; Chakravarti B; Singh US; Ansari MI; Deshpande S; Dwivedi SK; Bid HK; Konwar R; Kharkwal G; Chandra V; Dwivedi A; Hajela K
    Bioorg Med Chem; 2009 Jun; 17(11):3847-56. PubMed ID: 19423356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationships of 16-modified analogs of 2-methoxyestradiol.
    Agoston GE; Shah JH; Lavallee TM; Zhan X; Pribluda VS; Treston AM
    Bioorg Med Chem; 2007 Dec; 15(24):7524-37. PubMed ID: 17910916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.